BridgeBio Pharma, Inc. (BBIO)
73.48
-0.76
(-1.02%)
USD |
NASDAQ |
Dec 09, 12:03
BridgeBio Pharma Shareholders Equity (Quarterly): -1.933B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Supernus Pharmaceuticals, Inc. | 1.050B |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 998.25M |
| Total Liabilities (Quarterly) | 2.921B |
| Debt to Equity Ratio | -1.399 |
| Current Ratio | 3.875 |
| Net Debt Paydown Yield | -1.95% |